Skip to content

LSD: all studies

Page 64 of 282: studies 631 to 640 of 2,815, newest first. Back to the LSD overview

Research

125I-lysergic acid diethylamide binds to a novel serotonergic site on rat choroid plexus epithelial cells

Journal of Neuroscience December 1, 1985 K A Yagaloff, Hartig Pr 159 citations

125I-Lysergic acid diethylamide (125I-LSD) binds with high affinity to serotonergic sites on rat choroid plexus. These sites were localized to choroid plexus epithelial cells by use of a novel high resolution stripping film technique for light microscopic autoradiography. In membrane preparations from rat choroid plexus, the serotonergic site density was 3100 fmol/mg of protein, which is...

Ascorbic acid antagonizes the behavioural effects of LSD in cats.

Journal of Pharmacy and Pharmacology December 1, 1985 Michael E. Trulson, Terriann Crisp, Leslie J. Henderson

Pretreatment with ascorbic acid (500 mg kg-1 i.p.) antagonized the behavioural effects of lysergic acid diethylamide (LSD) and apomorphine, but not 5-methoxy-N,N-dimethyltryptamine, in cats. The data support the hypothesis that these behavioural effects in cats are due to drug action at both 5-HT and dopamine receptors, and that the action of LSD at dopamine receptors is modulated by ascorbic...

LSD: The Varieties of Psychotic Experience

Journal of Psychoactive Drugs October 1, 1985 Sidney Cohen 19 citations

The varieties of psychotic LSD experiences are many. A very few may resemble a delirium, some are quite reminiscent of schizophrenia and others have an idiosyncratic quality not seen in the naturally occurring psychoses. The psychotic response to LSD is better understood than transcendent experiences because its neurochemistry and phenomenology have been worked out. Additionally, there is...

DOI: 10.1080/02791072.1985.10524333 (opens in new tab) Hallucinogen Phenomenology philosophy Neurochemistry Psychosis +3

LSD and Psychotherapy

Journal of Psychoactive Drugs October 1, 1985 Richard Yensen 20 citations

A review of the historical trends in LSD research clearly indicates that LSD and similar drugs are too powerful and unique in their psychological effects to be mistaken for and studied as just another group of psychotropic compounds. The importance of the theoretical understanding and expectations of the researchers in determining the subjective effects and results of LSD treatment is...

DOI: 10.1080/02791072.1985.10524331 (opens in new tab) Consciousness Psychotherapist Process computing Relation database +1

Synthesis and LSD-like discriminative stimulus properties in a series of N(6)-alkyl norlysergic acid N,N-diethylamide derivatives

Journal of Medicinal Chemistry September 1, 1985 Andrew J. Hoffman, David E. Nichols 44 citations

A convenient method for the synthesis of N(6)-alkyl norlysergic acid N,N-diethylamide derivatives was developed. A series of these compounds was synthesized and tested for substitution in the two-lever drug discrimination assay, in rats trained to discriminate injections of d-LSD tartrate (185.5 nmol/kg, ip) from saline. A dose-response curve for each of the compounds in the series was...

DOI: 10.1021/jm00147a022 (opens in new tab) Lysergic acid diethylamide Alkyl Stimulus control Discriminative model +1

Discriminative stimulus properties of lysergic acid diethylamide in the monkey.

Journal of Pharmacology and Experimental Therapeutics July 1, 1985 E. B. Nielsen

Four monkeys (Cercopithecus aethiops) were trained to discriminate 0.06 mg/kg of lysergic acid diethylamide (LSD) from saline in a two-key task in which correct responding was reinforced with food under a fixed ratio 32 schedule. The ED50 of LSD was 0.011 mg/kg. The nonhallucinogenic ergot, lisuride, and the hallucinogen, 5-methoxy-N,N-dimethyltryptamine, substituted completely for LSD (ED50...

Increased platelet membrane [3H]‐LSD binding in patients on chronic neuroleptic treatment.

British Journal of Clinical Pharmacology April 1, 1985 Michael Schächter, David P. Geaney, Dg Grahame‐smith et al. 20 citations

Using a [3H]‐lysergic acid diethylamide [(3H]‐LSD) binding technique, platelet 5‐hydroxytryptamine (5‐HT) receptor number and affinity were compared in schizophrenics treated with depot thioxanthenes and phenothiazines and controls. There was an approximately 30% increase in platelet receptor number (Bmax) in the patient group. There was a decrease in affinity (increase in Kd) of about 30% in...